• 1654 Citations
  • 22 h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sanjay Goel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Neoplasms Medicine & Life Sciences
eribulin Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
docetaxel Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2002 2019

  • 1654 Citations
  • 22 h-Index
  • 71 Article
  • 2 Review article
  • 1 Chapter

Anti-PD-1 monoclonal antibody MEDI0680 in a phase i study of patients with advanced solid malignancies

Naing, A., Infante, J., Goel, S., Burris, H., Black, C., Marshall, S., Achour, I., Barbee, S., May, R., Morehouse, C., Pollizzi, K., Song, X., Steele, K., Elgeioushi, N., Walcott, F., Karakunnel, J., Lorusso, P., Weise, A., Eder, J., Curti, B. & 1 others, Oberst, M., Aug 22 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 225.

Research output: Contribution to journalArticle

Open Access
Kidney Neoplasms
Melanoma
Pharmacokinetics
Monoclonal Antibodies
T-Lymphocytes

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

Goel, S., Swami, U., Kumar, K., Dittrich, C., Reyderman, L., Jain, M., Aisner, J., Song, J. & Petrylak, D. P., Jan 1 2019, In : Cancer Chemotherapy and Pharmacology.

Research output: Contribution to journalArticle

eribulin
Carboplatin
Non-Small Cell Lung Carcinoma
Labels
Tumors
2 Citations (Scopus)

Novel patterns of response under immunotherapy

Borcoman, E., Kanjanapan, Y., Champiat, S., Kato, S., Servois, V., Kurzrock, R., Goel, S., Bedard, P. & Le Tourneau, C., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 385-396 12 p.

Research output: Contribution to journalReview article

Open Access
Immunotherapy
Therapeutics
Disease Progression
Melanoma
Neoplasms
Hispanic Americans
Prostatic Neoplasms
Neoplasm Grading
Population
Social Class

Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib

Augustine, T. A., Maitra, R., Zhang, J., Nayak, J. & Goel, S., Jan 1 2019, (Accepted/In press) In : Investigational New Drugs.

Research output: Contribution to journalArticle

irinotecan
Colorectal Neoplasms
Microsatellite Repeats
Apoptosis
HCT116 Cells